Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 5, 2005, Pages 665-670

  Vranken, Jan H ^a   Van Der Vegt, M H ^a   Van Kan, H J M ^a   Kruis, M R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer pain; Catheter; Intrathecal treatment; Meperidine; Neuropathic pain; Normeperidine; Toxicity

Indexed keywords

CLONIDINE; FENTANYL; MORPHINE; MORPHINE SULFATE; NORPETHIDINE; PETHIDINE;

ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; NEUROTOXICITY; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL ANESTHESIA;

AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MEPERIDINE; MIDDLE AGED; NEOPLASMS; PAIN, INTRACTABLE; QUALITY OF LIFE;

EID: 17844387368     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00667.x     Document Type: Article

References (26)

1. Ashburn MA, Lipman AG. Management of pain in the cancer patient. Anesth Analg 1993; 76: 402-16.
2. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion on 53 patients. J Neurosurg 1990; 72: 200-9.
3. Osenbach RK, Harvey S. Neuraxial infusion in patients with chronic intractable cancer and noncancer pain. Curr Pain Headache Rep 2001; 5: 241-9.
4. Yaksh TL, Harty GJ, Onofrio BM. High doses of spinal morphine produce a nonopiate receptor mediated hyperesthesia: Clinial and theoretic implications. Anesthesiology 1986; 64: 590-7.
5. Greene NN. Uptake and elimination of local anesthetics during spinal anesthesia. Anesth Analg 1983; 62: 1013-24.
6. van Dongen RTM, van Ee R, Crul BJP. Neurologic impairment during long-term intrathecal infusion of bupivacaine in cancer patients; a sign of spinal cord compression. Pain 1997; 69: 205-9.
7. Cousins MJ, Mather LE, Glynn CJ, Wilson PR, Graham JR. Selective spinal analgesia. Lancet 1979; I: 1141-2.
8. Jaffe RA, Rowe MA. A comparison of the local anesthetic effects of meperidine, fentanyl, and sufentanil on dorsal root axons. Anesth Analg 1996; 83: 776-81.
9. Ngan Kee WD. Epidural meperidine: Pharmacology and clinical experience. Anaesth Intensive Care 1998; 26: 247-55.
10. Aaronson NK, Ahmedzai S, Herman B. The European Organisation for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Nat C I 1993; 85: 365-76.
11. Carr DB, Cousins MJ. Spinal route of analgesia: Opioids and future options. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. Philadelphia: Lippincott-Raven Publishers, 1998: 915-83.
12. Hanks GW, Justins DM. Cancer pain: management. Lancet 1992; 339: 1031-6.
13. van Dongen RTM, Crul BJP, de Bock M. Long-term intrathecal infusion of morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain 1993; 55: 119-23.
14. Harvey SC, O'Neill MG, Pope CA, Cuddy BG, Due TA. Continuous intrathecal meperidine via an implantable infusion pump for chronic, non-malignant pain. Ann Pharmacother 1997; 31: 1306-8.
15. Hansen D, Hansen S. The effects of three grade doses of meperidine for spinal anesthesia in African men. Anesth Analg 1999; 88: 827-30.
16. Blythe JG, Hodel KA, Wahl TM et al. Continuous postoperative analgesia for gynecologic oncology patients. Gynecol Oncol 1990; 37: 307-10.
17. Inturrisi X, Umans JG. Meperidine and its active metabolite: Normeperidine. In: Bullingham RES, ed. Opiate Analgesia. Clinics in Anesthesiology. London: W.B. Saunders, 1983: 123-38.
18. Hagmeyer KO, Mauro LS, Mauro VF. Meperidine-related seizures associated with patient-controlled analgesia pumps. Ann Pharmacother 1993; 27: 29-32.
19. McHugh GJ. Norpethidine accumulation and generalized seizure during pethidine patient-controlled analgesia. Anaesth Intensive Care 1999; 27: 289-91.
20. Kaiko RF, Foley KM, Grabinsky PY et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180-5.
21. Nordberg G, Hansdottir V, Bondesson U et al. CSF and plasma pharmacokinetics of meperidine and normeperidine in man after epidural and intrathecal administration of meperidine. Eur J Clin Pharmacol 1988; 34: 625-31.
22. Julius HC, Levine HL, Williams WD. Meperidine binding to isolated a 1-acid glycoprotein and albumin. DICP 1989; 23: 568-72.
23. Uslu C, Taysi S, Akcay F, Sutbeyaz MY, Bakan N. Serum free and bound slialic acid and alpha-1-acid glycoprotein in patients with laryngeal cancer. Ann Clin Laboratory Sci 2003; 33: 156-9.
24. Eisenach JC, De Kock M, Klimscha W. Alpha 2 adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984-95). Anesthesiology 1996; 85: 655-74.
25. Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer-related pain. Pain 1983; 17: 277-88.
26. Yaksh TL, Rathbun ML, Provencher JC. Preclinical safety evaluation for spinal drugs. In: Yaksh TL, ed. Spinal Drug Delivery. Amsterdam: Elsevier Science B.V., 1999: 417-37.